Literature DB >> 21627476

Assessment of cardiac dynamics during stress echocardiography by the peak power output-to-left ventricular mass ratio.

Frank L Dini1.   

Abstract

Peak cardiac power-to-mass and peak mass-to-power are variables that couple cardiac power output with left ventricular (LV) mass at peak exercise or during maximal inotropic stimulation. Quantitative stress echocardiography enables the calculation of power output according to the formula: 133 × 10(-6) × stroke volume per second (ml) × mean blood pressure (BP; mmHg) × heart rate. Power-to-mass may be calculated as LV power output per 100 g of LV mass: 100 g × LV power output divided by LV mass (W/100 g). Conversely, mass-to-power may be estimated by dividing LV mass index by LV power output (g/m(2)/W). With a little rearrangement of the formulas we can write: power-to-mass (W/100 g) = 0.222 × cardiac output (l/min) × mean BP (mmHg)/LV mass (g) and mass-to-power (g/m(2)/W) = LV mass index/0.00222 × cardiac output (l/min) × mean BP (mmHg). These parameters reflect the energy delivery of ventricular myocardium with respect to potential energy that is stored in LV mass. The assessment of peak power-to-mass and peak mass-to-power indices may be useful to distinguish compensatory versus maladaptive remodeling in patients with LV dysfunction. When the integrity of myocardial structure is compromised, a disproportion becomes apparent between maximal cardiac power output and LV mass and this leads to either a reduction of peak power-to-mass or an increase of peak mass-to-power. Preliminary reports have demonstrated the usefulness and the prognostic value of peak power-to-mass and peak mass-to-power in patients with LV systolic dysfunction and coronary artery disease.

Entities:  

Mesh:

Year:  2011        PMID: 21627476     DOI: 10.2217/fca.11.12

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  1 in total

1.  Post-exertional increase in first-phase ejection fraction in recreational marathon runners.

Authors:  Luca Faconti; Iain Parsons; Bushra Farukh; Ryan McNally; Lorenzo Nesti; Lingyun Fang; Michael Stacey; Neil Hill; David Woods; Phil Chowienczyk
Journal:  JRSM Cardiovasc Dis       Date:  2020-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.